Trial intelligence / Profile preview

Dexmedetomidine microneedle patch for preoperative sedation in children aged 2 to 6 years

CTR20253327Phase 2Active

Sponsor
Xinji Pharma
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dexmedetomidine in Procedural anxiety, None, sponsored by Xinji Pharma. Started Aug 2025; status: active.

02

Drugs

dexmedetomidine
03

Conditions

Procedural anxiety

Beyond the preview

Go deeper on CTR20253327.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20253327.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call